About CD Diagnostics
CD Diagnostics is a Healthcare company based in Claymont (United States) founded in 2008, and was acquired by Zimmer Biomet in August 2016. Synovial fluid is tested for biomarkers in orthopedic disorders. CD Diagnostics has raised $6.61 million across 4 funding rounds from investors including Delaware.gov, Zimmer Biomet and Ben Franklin Technology Partners. The company has 56 employees. Its focus areas include Life Sciences, Orthopedics and In Vitro Diagnostic Tests. Its legal entity is CD DIAGNOSTICS, INC. Its competitors include MuscleSound, NueVue Solutions and CrescentDX; 2 of its 3 listed competitors have raised funding.
Company details
CD Diagnostics provides a range of biomarker assays testing synovial fluid for orthopedic disorders through its subsidiary Citrano Lab. The company offers the proprietary Synovasure PJI and NSA test (for alpha defensin, C-reactive protein hemoglobin) and the Synovasure Metal Ion test (cobalt and nickel). In addition, a suite of traditional orthopedic diagnostic tests are also offered.
- Headquarters Claymont, United States
- Employees 56
- Stage Acquired
- SectorsHealthcare
- Website cddiagnostics.com
- Social LinkedIn X
- Acquired by Zimmer Biomet (Aug 2016)
- Legal Name Cd Diagnostics, Inc.
- Total Equity Funding$6.61M (USD)
in 4 rounds
- Latest Funding Round$500K (USD), Grant
May 2014
- InvestorsDelaware.gov
& 4 more
- Employee Count56
- Acquired byZimmer Biomet
(Aug 2016)
Funding Insights of CD Diagnostics
CD Diagnostics has successfully raised a total of $6.61M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $500 thousand completed in May 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.61M
- Total Rounds 4
- Last Round Grant — $500,000
- First Round $1.34M
(Dec 2011)
- Investors Count 4
All 4 funding rounds of CD Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2014 | $500,000 | Grant | – | – | |
| Sep 2012 | $5M | Series A | – | Vital Venture Capital, Ben Franklin Technology Partners | – |
| Jan 2012 | $275,000 | Seed | – | – | |
| Dec 2011 | $1.34M | Seed | – | – | – |
5 investors in total: 5 institutional.
Investors in CD Diagnostics
CD Diagnostics has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Delaware.gov, Zimmer Biomet and Ben Franklin Technology Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private investments are made in early and later-stage businesses. | 2017 | vitalvc.com | Washington, DC, USA | |
Investment and support are provided for Pennsylvania's tech-based companies. | 1983 | benfranklin.org | State College, United States | |
Healthtech startups are funded by BioStar Capital's venture capital efforts. | biostarcapital.com | Charlevoix, United States | ||
Information on state government, programs, and services is provided. | delaware.gov | United States | ||
Medical devices for multiple health purposes are manufactured. | 1927 | zimmerbiomet.com | Warsaw, United States |
Investor details for CD Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of CD Diagnostics
4 dated milestones of CD Diagnostics across 8 years, from founding to its latest funding, stage changes and deals.
- Founded CD Diagnostics is founded.
- Funding First funding round of $1.3M.
- Funding Latest funding round, Grant, of $500K.
- Exit Acquired by Zimmer Biomet.
Competitors of CD Diagnostics
CD Diagnostics has 3 listed competitors in our database, 2 of them funded. They include MuscleSound, NueVue Solutions and CrescentDX.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| musclesound.com | 2011 | Denver, United States | $8.9M | Muscular glycogen levels are measured non-invasively via ultrasound. | ||
| nuevuesolutions.com | 1970 | Rootstown, United States | Orthopaedic therapy systems and services are provided using TSMI technology. | |||
| crescentdx.com | 2011 | Belfield, United States | $2.16M | Develops and markets diagnostic screening tests for osteoporosis. |
Detailed competitors of CD Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of CD Diagnostics
The website of CD Diagnostics (cddiagnostics.com) receives about 1K visits a month.
- Monthly visits1K
▲ 81% vs previous month
Top companies in Orthopedics
3 companies that operate in the same segment as CD Diagnostics (Orthopedics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cd Diagnostics
Complete news archive for CD Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CD Diagnostics
CD Diagnostics was founded in 2008 and raised its 1st funding round 3 years after it was founded.
CD Diagnostics is headquartered in Claymont, United States. It is registered at Claymont, Delaware, United States.
CD Diagnostics is a funded company, having raised a total of $6.61M across 4 funding rounds to date. The company's 1st funding round was a Seed of $1.34M, raised on Dec 2011.
CD Diagnostics has 56 employees.
CD Diagnostics provides a range of biomarker assays testing synovial fluid for orthopedic disorders through its subsidiary Citrano Lab. The company offers the proprietary Synovasure PJI and NSA test (for alpha defensin, C-reactive protein hemoglobin) and the Synovasure Metal Ion test (cobalt and nickel). In addition, a suite of traditional orthopedic diagnostic tests are also offered.
CD Diagnostics's top competitors include MuscleSound, NueVue Solutions and CrescentDX.
CD Diagnostics has 5 investors. Key investors include Delaware.gov, Zimmer Biomet, Ben Franklin Technology Partners, Vital Venture Capital, and BioStar Capital.
CD Diagnostics operates through Cd Diagnostics, Inc..
Yes. CD Diagnostics was acquired by Zimmer Biomet in August 2016.